Non-Canonical BAF and mSWI/SNF Regulates POU2F3 and are Selective Targetable Dependencies for POU2F3-Positive Small Cell Lung Cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 125 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Small cell lung cancerThis series is part of our curated briefing on it.
- Samples
- 125 samples: 125 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerCancer cell · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE249362_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1048875 and SRA study SRP476060. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 125 sample titles: 125 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7937497 20230718_KS127_ChIP_NCIH1048_DMSO_RPB1_DX2_rep1
- GSM7937498 20230718_KS128_ChIP_NCIH1048_DMSO_H3K27ac_DX2_rep1
- GSM7937499 20230718_KS129_ChIP_NCIH1048_DMSO_BRD9_DX2_rep1
- GSM7937500 20230718_KS131_ChIP_NCIH1048_DMSO_POU2F3_DX2_rep1
- GSM7937501 20230718_KS132_ChIP_NCIH1048_DMSO_Input_DX2
- GSM7937502 20230718_KS135_ChIP_NCIH1048_FHD286_RPB1_DX2_rep1
- GSM7937503 20230718_KS136_ChIP_NCIH1048_FHD286_H3K27ac_DX2_rep1
- GSM7937504 20230718_KS137_ChIP_NCIH1048_FHD286_BRD9_DX2_rep1
- GSM7937505 20230718_KS139_ChIP_NCIH1048_FHD286_POU2F3_DX2_rep1
- GSM7937506 20230718_KS140_ChIP_NCIH1048_FHD286_Input_DX2
- GSM7937507 20231109_KS157_ChIP_DMSO_POU2F3_DX2_rep2
- GSM7937508 20231109_KS158_ChIP_DMSO_H3K27ac_DX2_rep2
- GSM7937509 20231109_KS160_ChIP_DMSO_Input_DX2_rep3
- GSM7937510 20231109_KS164_ChIP_FHD609_POU2F3_DX2_rep2
- GSM7937511 20231109_KS165_ChIP_FHD609_H3K27ac_DX2_rep1
- GSM7937512 20230824_KSA041_NCIH211_DMSO_rep1
- GSM7937513 20230824_KSA042_NCIH211_DMSO_rep2
- GSM7937514 20230824_KSA043_NCIH211_FHD286_rep1
- GSM7937515 20230824_KSA044_NCIH211_FHD286_rep2
- GSM7937516 20230824_KSA045_NCIH211_FHD286_rep3
- GSM7937517 20230824_KSA046_CORL311_DMSO_rep1
- GSM7937518 20230824_KSA047_CORL311_DMSO_rep2
- GSM7937519 20230824_KSA048_CORL311_DMSO_rep3
- GSM7937520 20230824_KSA049_CORL311_FHD286_rep1
- GSM7937521 20230824_KSA050_CORL311_FHD286_rep2
- GSM7937522 20230824_KSA051_CORL311_FHD286_rep3
- GSM7937523 20230824_KSA052_NCIH526_DMSO_rep1
- GSM7937524 20230824_KSA053_NCIH526_DMSO_rep2
- GSM7937525 20230824_KSA054_NCIH526_DMSO_rep3
- GSM7937526 20230824_KSA055_NCIH526_FHD286_rep1
- GSM7937527 20230824_KSA056_NCIH526_FHD286_rep2
- GSM7937528 20230824_KSA057_NCIH526_FHD286_rep3
- GSM7937529 20230824_KSA058_NCIH1048_DMSO_rep1
- GSM7937530 20230824_KSA059_NCIH1048_DMSO_rep2
- GSM7937531 20230824_KSA060_NCIH1048_FHD286_rep1
- GSM7937532 20230824_KSA061_NCIH1048_FHD286_rep2
- GSM7937533 20230824_KSA062_NCIH1048_FHD286_rep3
- GSM7937534 20230824_KSA063_NCIH211_DMSO_rep3
- GSM7937535 20230824_KSA064_NCIH211_DMSO_rep4
- GSM7937536 20230824_KSA065_NCIH211_FHD609_rep1
+ 85 more — browse all 125 samples with per-sample file links →
- GSE302002 Structural Basis of DNA-Dependent Coactivator Recruitment by the Tuft Cell Master Regulator POU2F3 [RNA-seq] 18 samples same disease briefing · shares pou2f3
- GSE278238 Differential gene expression in paired H1092_Baf vs. H1092 6 samples same disease briefing · shares baf
- GSE64766 Selective Loss of RB in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to SCLC 16 samples same disease briefing · shares selective
- GSE310962 EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy 8 samples same disease briefing · shares targetable
- GSE296261 Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer 43 samples same disease briefing
- GSE239702 Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation 27 samples same disease briefing
- GSE259273 Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer 7 samples same disease briefing
- GSE272002 LSD1 inhibitor, TAS1440, disrupts INSM1-LSD1 complex activating tumor-suppressive pathways via transcriptional reprogramming in neuroendocrine SCLC 324 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.